XTX Topco’s Edwards Lifesciences EW Stock Holding History

XTX Topco’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	+14,110	New	+$1.18M	0.02%	1560
2025 Q4	–	Sell	-4,558	Closed	-$354K	–	3440
2025 Q3	$354K	Buy	+4,558	New	+$356K	0.02%	1377
2025 Q2	–	Sell	-27,622	Closed	-$2M	–	2588
2025 Q1	$2M	Buy	27,622 +6,722	+32%	+$481K	0.1%	259
2024 Q4	$1.55M	Sell	20,900 -32,396	-61%	-$2.27M	0.13%	141
2024 Q3	$3.52M	Buy	53,296 +21,814	+69%	+$1.58M	0.25%	31
2024 Q2	$2.91M	Buy	+31,482	New	+$2.79M	0.25%	51
2023 Q4	–	Sell	-8,020	Closed	-$556K	–	1739
2023 Q3	$556K	Buy	+8,020	New	+$644K	0.09%	335
2023 Q1	–	Sell	-8,194	Closed	-$611K	–	1393
2022 Q4	$611K	Buy	8,194 +252	+3%	+$19.4K	0.13%	215
2022 Q3	$656K	Buy	+7,942	New	+$764K	0.16%	140
2022 Q2	–	Sell	-3,005	Closed	-$354K	–	927
2022 Q1	$354K	Buy	+3,005	New	+$337K	0.16%	220

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

XTX Topco's EW Position: Q2 2026 in Review

XTX Topco opened a new position in Edwards Lifesciences (EW) in Q2 2026: 14,110 shares worth $1.28M. The stake represents 0.02% of the portfolio and ranks #1560 among its holdings. This is a return to the name: XTX Topco previously reported a position in EW as recently as Q3 2025.

XTX Topco first reported a position in EW in Q1 2022 and has held it in 10 quarters since. The position peaked at $3.52M in Q3 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

XTX Topco held 14,110 shares of Edwards Lifesciences worth $1.28M as of Q2 2026.
Edwards Lifesciences was a new XTX Topco position in Q2 2026.
Edwards Lifesciences made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1560 holding.
XTX Topco first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 10 quarters since.
XTX Topco's Edwards Lifesciences position peaked at $3.52M in Q3 2024.
1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.